SV2002000343A - Composisiones farmaceuticas de inhibidores de la glucogeno fosforilasa ref. pc10882/20147/bb - Google Patents
Composisiones farmaceuticas de inhibidores de la glucogeno fosforilasa ref. pc10882/20147/bbInfo
- Publication number
- SV2002000343A SV2002000343A SV2001000343A SV2001000343A SV2002000343A SV 2002000343 A SV2002000343 A SV 2002000343A SV 2001000343 A SV2001000343 A SV 2001000343A SV 2001000343 A SV2001000343 A SV 2001000343A SV 2002000343 A SV2002000343 A SV 2002000343A
- Authority
- SV
- El Salvador
- Prior art keywords
- glucogeno
- pharmaceutical
- fosforilasa
- composisions
- ref
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Communicable Diseases (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oncology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Indole Compounds (AREA)
Abstract
COMPOSICIONES FARMACEUTICAS QUE CONTIENEN UN INHIBIDOR DE LA GLUCOGENO-FOSFORILASA Y COMO MINIMO UN POLIMERO QUE AUMENTA LA CONCENTRACION. LA COMPOSICION PUEDE SER UNA MEZCLA FISICA SIMPLE DE UN INHIBIDOR DE LA GLUCOGENO-FOSFORILASA Y UN POLIMERO QUE AUMENTA LA CONCENTRACION, O UNA DISPERSION DE UN INHIBIDOR DE LA GLUCOGENO-FOSFORILASA Y UN POLIMERO.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18994200P | 2000-03-16 | 2000-03-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
SV2002000343A true SV2002000343A (es) | 2002-07-03 |
Family
ID=22699402
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SV2001000343A SV2002000343A (es) | 2000-03-16 | 2001-03-15 | Composisiones farmaceuticas de inhibidores de la glucogeno fosforilasa ref. pc10882/20147/bb |
Country Status (32)
Country | Link |
---|---|
US (1) | US20010053778A1 (es) |
EP (1) | EP1263414A1 (es) |
JP (1) | JP2003526654A (es) |
KR (1) | KR20020081445A (es) |
CN (1) | CN1418089A (es) |
AP (1) | AP2002002621A0 (es) |
AR (1) | AR027656A1 (es) |
AU (1) | AU2001242669A1 (es) |
BG (1) | BG107037A (es) |
BR (1) | BR0109189A (es) |
CA (1) | CA2403241A1 (es) |
CO (1) | CO5280087A1 (es) |
CZ (1) | CZ20022955A3 (es) |
EA (1) | EA200200858A1 (es) |
EE (1) | EE200200530A (es) |
HU (1) | HUP0204583A2 (es) |
IL (1) | IL151320A0 (es) |
IS (1) | IS6508A (es) |
MA (1) | MA26882A1 (es) |
MX (1) | MXPA02009097A (es) |
NO (1) | NO20024386L (es) |
OA (1) | OA12232A (es) |
PA (1) | PA8513601A1 (es) |
PE (1) | PE20011184A1 (es) |
PL (1) | PL360780A1 (es) |
SK (1) | SK12622002A3 (es) |
SV (1) | SV2002000343A (es) |
TN (1) | TNSN01040A1 (es) |
TR (1) | TR200202184T2 (es) |
WO (1) | WO2001068055A1 (es) |
YU (1) | YU67202A (es) |
ZA (1) | ZA200207290B (es) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU784340B2 (en) * | 1999-12-23 | 2006-03-16 | Pfizer Products Inc. | Pharmaceutical compositions providing enhanced drug concentrations |
CO5271699A1 (es) * | 2000-01-24 | 2003-04-30 | Pfizer Prod Inc | Procedimiento para el tratamiento de cardiomiopatia utilizando inhibidores de la glucogeno fosforilasa |
WO2003000238A1 (en) | 2001-06-22 | 2003-01-03 | Pfizer Products Inc. | Pharmaceutical compositions of adsorbates of amorphous drug |
MXPA03011935A (es) * | 2001-06-22 | 2004-03-26 | Pfizer Prod Inc | Composiciones farmaceuticas que contienen conjuntos de polimero y farmaco. |
EP1269994A3 (en) * | 2001-06-22 | 2003-02-12 | Pfizer Products Inc. | Pharmaceutical compositions comprising drug and concentration-enhancing polymers |
CA2450957A1 (en) * | 2001-06-22 | 2003-01-03 | Pfizer Products Inc. | Pharmaceutical compositions of dispersions of drugs and neutral polymers |
KR100758045B1 (ko) | 2002-02-01 | 2007-09-11 | 화이자 프로덕츠 인크. | 압력 노즐을 이용하여 균질한 분무 건조된 비결정질 고체약물 분산제를 제조하는 방법 |
CA2472028C (en) * | 2002-02-01 | 2010-03-30 | Pfizer Products Inc. | Method for making homogeneous spray-dried solid amorphous drug dispersions utilizing modified spray-drying apparatus |
JP2005523262A (ja) | 2002-02-01 | 2005-08-04 | ファイザー・プロダクツ・インク | 薬物及び親油性ミクロ相形成物質の非晶質分散物の医薬組成物 |
GB0205175D0 (en) | 2002-03-06 | 2002-04-17 | Astrazeneca Ab | Chemical compounds |
GB0205165D0 (en) | 2002-03-06 | 2002-04-17 | Astrazeneca Ab | Chemical compounds |
GB0205162D0 (en) | 2002-03-06 | 2002-04-17 | Astrazeneca Ab | Chemical compounds |
GB0205170D0 (en) | 2002-03-06 | 2002-04-17 | Astrazeneca Ab | Chemical compounds |
GB0205166D0 (en) | 2002-03-06 | 2002-04-17 | Astrazeneca Ab | Chemical compounds |
GB0205176D0 (en) | 2002-03-06 | 2002-04-17 | Astrazeneca Ab | Chemical compounds |
US7405210B2 (en) | 2003-05-21 | 2008-07-29 | Osi Pharmaceuticals, Inc. | Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase |
CL2004001884A1 (es) | 2003-08-04 | 2005-06-03 | Pfizer Prod Inc | Procedimiento de secado por pulverizacion para la formacion de dispersiones solidas amorfas de un farmaco y polimeros. |
JP2007501218A (ja) | 2003-08-04 | 2007-01-25 | ファイザー・プロダクツ・インク | 非晶質薬物の吸着物および親油性ミクロ相形成物質の医薬組成物 |
US7390503B1 (en) | 2003-08-22 | 2008-06-24 | Barr Laboratories, Inc. | Ondansetron orally disintegrating tablets |
EP1701704A2 (en) * | 2003-12-31 | 2006-09-20 | Pfizer Products Inc. | Solid compositions of low-solubility drugs and poloxamers |
US7884112B2 (en) | 2004-03-08 | 2011-02-08 | Stuart Edward Bradley | Pyrrolopyridine-2-carboxylic acid hydrazides |
WO2006059163A1 (en) * | 2004-12-02 | 2006-06-08 | Prosidion Limited | Treatment of diabetes with glycogen phosphorylase inhibitors |
DE102005026755A1 (de) * | 2005-06-09 | 2006-12-14 | Basf Ag | Herstellung von festen Lösungen schwerlöslicher Wirkstoffe durch Kurzzeitüberhitzung und schnelle Trocknung |
MX2015002429A (es) | 2012-08-24 | 2015-06-22 | Dow Global Technologies Llc | Eteres de celulosa esterificados novedosos de alto peso molecular y homogeneidad. |
CN109897004A (zh) | 2012-09-11 | 2019-06-18 | 麦迪威森***医疗有限责任公司 | 恩杂鲁胺制剂 |
CN105307636A (zh) | 2013-07-19 | 2016-02-03 | 西佳技术公司 | 非晶形特考韦瑞制备 |
CN103709171B (zh) * | 2014-01-20 | 2015-09-16 | 武汉大学 | 具有哒嗪并[3,4-b]吲哚骨架结构的衍生物及其合成方法 |
CN112442022B (zh) * | 2019-09-02 | 2022-05-20 | 承德医学院 | 苯并嗪-4-酮类化合物、其制备方法及医药用途 |
US11291701B1 (en) * | 2021-02-04 | 2022-04-05 | Seed Edibles | Orally disintegrating, sublingual and buccal formulations |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6107329A (en) * | 1995-06-06 | 2000-08-22 | Pfizer, Inc. | Substituted n-(indole-2-carbonyl)-glycinamides and derivatives as glycogen phosphorylase inhibitors |
DE69522718T2 (de) * | 1995-06-06 | 2002-02-07 | Pfizer | Substituierte n-(indol-2-carbonyl)-amide und derivate als glycogen phosphorylase inhibitoren |
ES2287971T3 (es) * | 1997-08-11 | 2007-12-16 | Pfizer Products Inc. | Dispersiones farmaceuticas solidas con biodisponibilidad incrementada. |
US5998463A (en) * | 1998-02-27 | 1999-12-07 | Pfizer Inc | Glycogen phosphorylase inhibitors |
-
2001
- 2001-03-14 PE PE2001000246A patent/PE20011184A1/es not_active Application Discontinuation
- 2001-03-14 US US09/805,828 patent/US20010053778A1/en not_active Abandoned
- 2001-03-14 AR ARP010101185A patent/AR027656A1/es not_active Application Discontinuation
- 2001-03-15 TN TNTNSN01040A patent/TNSN01040A1/fr unknown
- 2001-03-15 SV SV2001000343A patent/SV2002000343A/es not_active Application Discontinuation
- 2001-03-16 YU YU67202A patent/YU67202A/sh unknown
- 2001-03-16 BR BR0109189-1A patent/BR0109189A/pt not_active Application Discontinuation
- 2001-03-16 TR TR2002/02184T patent/TR200202184T2/xx unknown
- 2001-03-16 CN CN01806619A patent/CN1418089A/zh active Pending
- 2001-03-16 CZ CZ20022955A patent/CZ20022955A3/cs unknown
- 2001-03-16 JP JP2001566619A patent/JP2003526654A/ja active Pending
- 2001-03-16 PA PA20018513601A patent/PA8513601A1/es unknown
- 2001-03-16 AU AU2001242669A patent/AU2001242669A1/en not_active Abandoned
- 2001-03-16 CA CA002403241A patent/CA2403241A1/en not_active Abandoned
- 2001-03-16 WO PCT/IB2001/000394 patent/WO2001068055A1/en not_active Application Discontinuation
- 2001-03-16 EP EP01915586A patent/EP1263414A1/en not_active Withdrawn
- 2001-03-16 AP APAP/P/2002/002621A patent/AP2002002621A0/en unknown
- 2001-03-16 EE EEP200200530A patent/EE200200530A/xx unknown
- 2001-03-16 SK SK1262-2002A patent/SK12622002A3/sk unknown
- 2001-03-16 CO CO01021769A patent/CO5280087A1/es not_active Application Discontinuation
- 2001-03-16 KR KR1020027012009A patent/KR20020081445A/ko not_active Application Discontinuation
- 2001-03-16 PL PL36078001A patent/PL360780A1/xx not_active Application Discontinuation
- 2001-03-16 HU HU0204583A patent/HUP0204583A2/hu unknown
- 2001-03-16 EA EA200200858A patent/EA200200858A1/ru unknown
- 2001-03-16 OA OA1200200290A patent/OA12232A/en unknown
- 2001-03-16 IL IL15132001A patent/IL151320A0/xx unknown
- 2001-03-16 MX MXPA02009097A patent/MXPA02009097A/es unknown
-
2002
- 2002-08-16 IS IS6508A patent/IS6508A/is unknown
- 2002-08-26 BG BG107037A patent/BG107037A/bg unknown
- 2002-09-11 MA MA26810A patent/MA26882A1/fr unknown
- 2002-09-11 ZA ZA200207290A patent/ZA200207290B/xx unknown
- 2002-09-13 NO NO20024386A patent/NO20024386L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
IL151320A0 (en) | 2003-04-10 |
AR027656A1 (es) | 2003-04-09 |
PL360780A1 (en) | 2004-09-20 |
TR200202184T2 (tr) | 2003-01-21 |
NO20024386D0 (no) | 2002-09-13 |
ZA200207290B (en) | 2003-09-11 |
WO2001068055A1 (en) | 2001-09-20 |
PE20011184A1 (es) | 2001-11-15 |
YU67202A (sh) | 2006-01-16 |
BR0109189A (pt) | 2003-05-27 |
EE200200530A (et) | 2004-04-15 |
MA26882A1 (fr) | 2004-12-20 |
EP1263414A1 (en) | 2002-12-11 |
CA2403241A1 (en) | 2001-09-20 |
AP2002002621A0 (en) | 2002-09-30 |
JP2003526654A (ja) | 2003-09-09 |
SK12622002A3 (sk) | 2004-02-03 |
MXPA02009097A (es) | 2003-03-12 |
CZ20022955A3 (cs) | 2003-09-17 |
OA12232A (en) | 2006-05-10 |
US20010053778A1 (en) | 2001-12-20 |
PA8513601A1 (es) | 2004-08-31 |
CO5280087A1 (es) | 2003-05-30 |
AU2001242669A1 (en) | 2001-09-24 |
CN1418089A (zh) | 2003-05-14 |
BG107037A (bg) | 2003-04-30 |
EA200200858A1 (ru) | 2003-02-27 |
HUP0204583A2 (hu) | 2003-04-28 |
NO20024386L (no) | 2002-11-13 |
TNSN01040A1 (fr) | 2005-11-10 |
IS6508A (is) | 2002-08-16 |
KR20020081445A (ko) | 2002-10-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SV2002000343A (es) | Composisiones farmaceuticas de inhibidores de la glucogeno fosforilasa ref. pc10882/20147/bb | |
SV2002000581A (es) | Composiciones farmaceuticas de inhibidores de la proteina de transferencia de colesteril ester ref.pc10754/700005/bb | |
SV2004001473A (es) | Composiciones farmaceuticas de inhibidores de la proteina de transferencia de esteres de colesterilo ref.pc 23132 | |
BR0207296A (pt) | Composição para revestimento | |
BR0207961A (pt) | Combinação de análogos da epotilona e agentes quimioterápicos para o tratamento de doenças proliferativas | |
BR0317715A (pt) | Composições e processos de uso de collajolie | |
BR0006005A (pt) | Composição estável de óleo em glicerinatopicamente aplicável | |
DE69928938D1 (de) | Neues cyclosporin mit verbesserter wirkung | |
BR0101304B1 (pt) | "composição de poliolefina que compreende uma mistura de absorvedores de uv e uso de uma mistura de absorvedores de uv". | |
CY1116023T1 (el) | Μορφες φαρμακευτικης δοσολογιας παρατεταμενης απελευθερωσης με περιγραμματα διαλυτοποιησης ελαχιστοποιημενης εξαρτησης απο το ph | |
DK1117440T3 (da) | Farmaceutiske sammensætninger indeholdende paclitaxel | |
ID26033A (id) | Metode penstabilan komposisi bahan farmasi dengan penggunaan khusus dari antioksidan | |
AR020345A1 (es) | Pirazol-carboxanilidas, procedimiento para su obtencion, composiciones, empleo de dichos compuestos y procedimiento para la lucha contra microorganismos indeseables, y procedimiento para la obtencion de dichas composiciones. | |
CY1105009T1 (el) | Συνθεση καχαλαλιδης f | |
DE69905170T2 (de) | Thiazolopyrimidinderivate | |
AU2003293555A1 (en) | 17 beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases | |
MXPA02012160A (es) | Composiciones medicinales las cuales contienen derivados de propenona. | |
NO20011017D0 (no) | Polymeriserings-inhibitering av styren-monomerer | |
AU2001275346A1 (en) | Compositions, kits, and methods for identification and modulation of type i diabetes | |
TR199802351T2 (xx) | Topikal kullanım için bir veya birden fazla lokal anestezik ve anti-vajinit maddeler ihtiva eden anti-vajinit bileşimi. | |
RS51534B (en) | NEW COMPOUND OF SINUSOID IF CURRENT INHIBITORS AND CALCIUM INHIBITOR AND PHARMACEUTICAL MIXTURE CONTAINED BY IT | |
BR0000544A (pt) | Poliolefinas de metaloceno estabilizadas | |
DE50205129D1 (de) | 8-tetradecenal als duft- oder aromastoff | |
ATE354291T1 (de) | Zusammensetzungen enthaltend mindestens kürbisöl und borretschöl, deren verwendung als arzneimittel, dermatikum oder dermatokosmetische zusammensetzung | |
ATE392644T1 (de) | Alpha-(1' -hydroxyalkyl)acrylate enthaltende beschichtungsmassen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Lapse |